Kansas City, MO, United States of America

Joshua Wears

This inventor holds 1 USPTO granted patent. Top assignee: Trinity Biotech, Primus Corporation. Active years: 2015.


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Joshua Wears in Chromatographic Analysis

Introduction

Joshua Wears is an accomplished inventor based in Kansas City, MO (US). He has made significant contributions to the field of biological analysis through his innovative patent. His work focuses on high-speed, automated chromatographic analyzers that enhance the determination of nonglycated and glycated proteinaceous species in blood samples.

Latest Patents

Joshua Wears holds a patent for a high-speed, automated chromatographic analyzer designed for the analysis of biological fluids, particularly whole blood or blood-derived components. This analyzer features specialized mechanisms that allow for injection-to-injection analysis times of approximately one minute. The technology is specifically tailored for High-Performance Liquid Chromatography (HPLC) analysis, targeting both glycated and nonglycated proteinaceous species in blood samples.

Career Highlights

Joshua is currently associated with Trinity Biotech and Primus Corporation, where he applies his expertise in developing advanced analytical technologies. His innovative approach has positioned him as a key player in the field of medical diagnostics.

Collaborations

Joshua has worked alongside notable colleagues, including Harold M Donley and Sam Schlageck. Their collaborative efforts contribute to the advancement of technologies in the medical and analytical fields.

Conclusion

Joshua Wears exemplifies innovation in the realm of chromatographic analysis, with his patented technology paving the way for faster and more efficient blood sample analysis. His contributions are vital to the ongoing development of medical diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…